GSK’s Oncology Portfolio in India to be Boosted by Jemperli and Zejula
GSK's India oncology portfolio is set to receive a significant boost with the introduction of…
GSK's India oncology portfolio is set to receive a significant boost with the introduction of…
Major pharmaceutical companies are partnering with Asian biotechs to tap into the region's innovative pipeline…
23andMe, a pioneer in direct-to-consumer genetic testing, has filed for bankruptcy and plans to sell…